Merck & Co
MSD gets CHMP positive opinion for keytruda to treat advanced lung cancer
June 28, 2016Manufacturing and Production, Research and Development, Sales and Marketing CHMP, EMA, MSD, Merck & Co, keytruda, lung cancer
MSD (Merck & Co) said its anti-programmed death-1 (PD-1) therapy, Keytruda (pembrolizumab) to treat lung cancer has secured a positive …
Merck & Co says Keytruda shows better results than chemotherapy in Phase III trials for lung cancer
June 17, 2016Medical Communications MSD, Merck & Co, drug trial, keytruda, lung cancer
US drug major Merck & Co (NYSE: MRK) said late-stage trials for its immunotherapy Keytruda (pembrolizumab) to treat advanced non-small-cell …
Merck & Co agrees to buy biotech firm Afferent for upfront $500 million in cash
June 10, 2016Medical Communications, Sales and Marketing Afferent Pharmaceuticals, Financial, M&A, MA, Merck & Co
US drugmaker Merck & Co (NYSE: MRK) said it has agreed to buy biotech firm Afferent Pharmaceuticals for an upfront …
MSD says Phase III trials for Keytruda to treat advanced melanoma shows better survival
June 8, 2016Research and Development ASCO, MSD, Merck & Co, PD-L1, advanced melanoma, drug trial, immuno-oncology, keytruda
Merck & Co (NYSE: MRK) said late-stage trials for its immunotherapy Keytruda (pembrolizumab) to treat advanced melanoma showed over half …
Merck & Co Q1 sales hurt by generics, currency impact
May 6, 2016Medical Communications, Sales and Marketing Financial, Merck & Co, Q1, Revenye, earnings, results, sales
US pharma major Merck & Co (NYSE: MRK) posted a drop in first-quarter sales impacted the launch of generic competition …
Merck says US FDA to review its Keytruda for head & neck cancer
April 14, 2016Research and Development, Sales and Marketing Cancer Immunotherapy, Merck & Co, US FDA, keytruda
The US Food and Drug Administration has accepted Merck & Co’s (NYSE: MRK) supplemental biologics license application (sBLA) for its immunotherapy cancer …
Merck says its Zepatier showed better efficacy and safety compared with competition in Phase III trials
April 14, 2016Research and Development, Sales and Marketing Gilead, HCV, Merck & Co, Zepatier
US pharma giant Merck (NYSE: MRK) on Thursday said late-stage trials for its Zepatier (elbasvir and grazoprevir) to treat chronic …
Merck & Co says study shows significantly higher persistence for its arthritis drug Simponi
March 17, 2016Research and Development, Sales and Marketing Merck & Co, drug trial, research, rheumatoid arthritis
US pharma giant Merck & Co (NYSE: MRK) said its rheumatoid arthritis drug showed significantly higher persistence compared with other drugs …
Merck says US FDA accepts its sBLA for Keytruda
March 8, 2016Manufacturing and Production, Research and Development Merck & Co, US FDA, keytruda, melanoma
US pharma giant Merck & Co said the US Food and Drug Administration (FDA) has accepted for review a new …
Merck unveils Brazilian joint venture
February 17, 2012Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets
Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …
Merck pays $1.5m penalty for US pollution
October 4, 2011Manufacturing and Production Merck & Co, pharma manufacturing news
Merck & Co has fallen foul of US regulations on environmental controls at two manufacturing plants and agreed to pay …
Merck’s COPD drug rejected by NICE
September 15, 2011Sales and Marketing Daxas, MSD, Merck & Co, NICE, roflumilast
NICE has not recommended Merck Co’s Daxas and has advised the firm to conduct a clinical trial in order to …
GSK-Merck back new developing world cancer charity
September 14, 2011Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer
GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …
Merck collaborates with China-based genomics specialist BGI
September 14, 2011Research and Development BGI, Merck & Co, biomarkers, genomics
Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …
Merck vaccines contaminated with plastic, says FDA
August 2, 2011Manufacturing and Production Contamination, Merck & Co, vaccines
Vaccines made by Merck & Co at its West Point facility in Philadelphia, US, have been found to be contaminated …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
